Activation of several Gi/o-coupled chemokine receptors, including CCR2, CXCR1, and CXCR2, by their cognate ligands was found to stimulate CSC activity in HER2+ breast cancer [20,21]. Here, CXCR2 is linked to breast carcinoma.